Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource

What this is

NHS England is conducting preliminary market engagement for three separate requirements within a Targeted Prostate Cancer Screening Programme: PSA testing services, MRI reporting services, and a BRCA digital decision resource. This is an early-stage market engagement notice to inform future procurement.

Key points

• This is a Preliminary Market Engagement Notice, not a formal tender — no binding procurement is active yet
• Three separate service requirements: PSA testing (medical laboratory services), MRI reporting (medical imaging), and BRCA digital decision resource
• Buyer is NHS England, London (SE1 8UG)
• CPV codes indicate health services, medical imaging, and laboratory analysis services
• No deadline, bid bond, or formal submission requirements stated in this engagement notice

Classification

CPV 85145000 — Services provided by medical laboratories 85100000 — Health services85150000 — Medical imaging services85148000 — Medical analysis services85145000 — Services provided by medical laboratories LondonUnited Kingdom